Jeil Pharma Holdings Inc (KRX:002620)
South Korea
· Delayed Price · Currency is KRW 8,560.00
-190.00 (-2.17%)
At close: Jun 27, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Pharmaceutical | 818.40B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Growth | 0.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Investment | 13.69B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Investment Growth | 17.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -28.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -28.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Consolidated Adjustment | -28.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 777.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -1.24% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | 54.92B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | 45.90% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -28.04B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | -11.23% |
Log In |
Log In |
Log In |
Log In | Upgrade
|